Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells*

Telomestatin is a potent G-quadruplex ligand that interacts with the 3′ telomeric overhang, leading to its degradation, and induces a delayed senescence and apoptosis of cancer cells. POT1 and TRF2 were recently identified as specific telomere-binding proteins involved in telomere capping and t-loop maintenance and whose interaction with telomeres is modulated by telomestatin. We show here that the treatment of HT1080 human tumor cells by telomestatin induces a rapid decrease of the telomeric G-overhang and of the double-stranded telomeric repeats. Telomestatin treatment also provokes a strong decrease of POT1 and TRF2 from their telomere sites, suggesting that the ligand triggers the uncapping of the telomere ends. The effect of the ligand is associated with an increase of the γ-H2AX foci, one part of them colocalizing at telomeres, thus indicating the occurrence of a DNA damage response at the telomere, but also the presence of additional DNA targets for telomestatin. Interestingly, the expression of GFP-POT1 in HT1080 cells increases both telomere and G-overhang length. As compared with HT1080 cells, HT1080GFP-POT1 cells presented a resistance to telomestatin treatment characterized by a protection to the telomestatin-induced growth inhibition and the G-overhang shortening. This protection is related to the initial G-overhang length rather than to its degradation rate and is overcome by increased telomestatin concentration. Altogether these results suggest that telomestatin induced a telomere dysfunction in which G-overhang length and POT1 level are important factors but also suggest the presence of additional DNA sites of action for the ligand.

[1]  T. Veldman,et al.  Loss of hPot1 Function Leads to Telomere Instability and a cut-like Phenotype , 2004, Current Biology.

[2]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[3]  J. Shay,et al.  Telomerase: a target for cancer therapeutics. , 2002, Cancer cell.

[4]  Patrick Mailliet,et al.  Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. , 2004, Biochemical and biophysical research communications.

[5]  J. Shay,et al.  Normal human chromosomes have long G-rich telomeric overhangs at one end. , 1997, Genes & development.

[6]  J. Griffith,et al.  T‐loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang , 2001, The EMBO journal.

[7]  Kazuo Shin-Ya,et al.  Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. , 2002, Journal of the American Chemical Society.

[8]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[9]  J. Mergny,et al.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Griffith,et al.  Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.

[11]  K. Shin‐ya,et al.  Interaction of Telomestatin with the Telomeric Single-strand Overhang* , 2004, Journal of Biological Chemistry.

[12]  S. Neidle,et al.  Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.

[13]  S. Neidle,et al.  Highly prevalent putative quadruplex sequence motifs in human DNA , 2005, Nucleic acids research.

[14]  E. Blackburn,et al.  Molecular manifestations and molecular determinants of telomere capping. , 2000, Cold Spring Harbor symposia on quantitative biology.

[15]  K. Shin‐ya,et al.  Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways , 2003, Oncogene.

[16]  K. Shin‐ya,et al.  G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells , 2006, Oncogene.

[17]  J. Zahm,et al.  Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence , 2005, Nucleic acids research.

[18]  J. Mergny,et al.  Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands , 2005, Oncogene.

[19]  K. Shin‐ya,et al.  Resistance to the Short Term Antiproliferative Activity of the G-quadruplex Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration* , 2003, Journal of Biological Chemistry.

[20]  J. Mergny,et al.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Blackburn,et al.  Telomeres and their control. , 2000, Annual review of genetics.

[22]  A. Smogorzewska,et al.  Senescence Induced by Altered Telomere State, Not Telomere Loss , 2002, Science.

[23]  David M. Prescott,et al.  Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.

[24]  Gary Parkinson,et al.  Telomere maintenance as a target for anticancer drug discovery , 2002, Nature Reviews Drug Discovery.

[25]  T. Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .

[26]  R. Verdun,et al.  Defective Telomere Lagging Strand Synthesis in Cells Lacking WRN Helicase Activity , 2004, Science.

[27]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[28]  Shankar Balasubramanian,et al.  Prevalence of quadruplexes in the human genome , 2005, Nucleic acids research.

[29]  J. Mergny,et al.  Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. , 2001, Nucleic acids research.

[30]  S. Neidle,et al.  A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.

[31]  B. Gilchrest,et al.  Evidence that exposure of the telomere 3′ overhang sequence induces senescence , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. V. Von Hoff,et al.  Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. , 2001, Molecular cancer therapeutics.

[33]  P. Baumann,et al.  Human POT1 Facilitates Telomere Elongation by Telomerase , 2003, Current Biology.

[34]  K. Shin‐ya,et al.  Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. , 2001, Journal of the American Chemical Society.

[35]  K. Shin‐ya,et al.  The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.

[36]  A. Smogorzewska,et al.  Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.

[37]  S. Neidle,et al.  2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.

[38]  P. Baumann,et al.  Pot1, the Putative Telomere End-Binding Protein in Fission Yeast and Humans , 2001, Science.

[39]  E. Gilson,et al.  Natural and pharmacological regulation of telomerase. , 2002, Nucleic acids research.

[40]  C. Harris,et al.  POT1 and TRF2 Cooperate To Maintain Telomeric Integrity , 2005, Molecular and Cellular Biology.

[41]  J. Langmore,et al.  Long G Tails at Both Ends of Human Chromosomes Suggest a C Strand Degradation Mechanism for Telomere Shortening , 1997, Cell.

[42]  K. Shin‐ya,et al.  Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. , 2003, Cancer research.

[43]  T. Cech,et al.  Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Hickson,et al.  Inhibition of the Bloom's and Werner's syndrome helicases by G-quadruplex interacting ligands. , 2001, Biochemistry.

[45]  L. Hurley,et al.  The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. , 2003, Cancer research.

[46]  T. Lange,et al.  DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion , 2005, Nature Cell Biology.